MSCI Transatlantic Biotechnology & Pharma Healthcare Access Top 30 Select 5% Decrement Index (Net)

The Index represents the performance of the top 30 large and mid cap Biotechnology and Pharmaceuticals companies by free float market cap from US and European developed markets, selected among those offering the highest access to health care, as measured by the MSCI Access to Health Care Score. The index applies a 5% annual decrement and is calculated on a net total return basis.